Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection
Clinical trial NCT01492426 · COMPLETED
Trial details
- NCT number
- NCT01492426
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.